GT Biopharma, Inc.GTBPNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank14
3Y CAGR+151.3%
5Y CAGR-47.9%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+151.3%/yr
vs -82.8%/yr prior
5Y CAGR
-47.9%/yr
Recent acceleration
Acceleration
+234.1pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $127000.00 | - |
| 2024 | $0.00 | -100.0% |
| 2023 | $213000.00 | +2562.5% |
| 2022 | $8000.00 | -98.9% |
| 2021 | $718000.00 | -78.4% |
| 2020 | $3.32M | +56.0% |
| 2019 | $2.13M | -76.7% |
| 2018 | $9.12M | +6.0% |
| 2017 | $8.60M | +31.2% |
| 2016 | $6.55M | - |